David A. Socks
Net Worth

Last updated:

What is David A. Socks net worth?

The estimated net worth of Mr. David A. Socks is at least $40,050,320 as of 8 Oct 2021. He owns shares worth $12,779,700 as insider, has earned $24,883,170 from insider trading and has received compensation worth at least $2,387,450 in Phathom Pharmaceuticals, Inc..

What is the salary of David A. Socks?

Mr. David A. Socks salary is $477,490 per year as Co-Founder & Director in Phathom Pharmaceuticals, Inc..

How old is David A. Socks?

Mr. David A. Socks is 51 years old, born in 1974.

What stocks does David A. Socks currently own?

As insider, Mr. David A. Socks owns shares in one company:

Company Title Shares Price per share Total value
Phathom Pharmaceuticals, Inc. (PHAT) Co-Founder & Director 1,211,346 $10.55 $12,779,700

What does Phathom Pharmaceuticals, Inc. do?

Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.

PHAT logo
PHAT
Phathom Pharmaceuticals, Inc.
$10.55

David A. Socks insider trading

Phathom Pharmaceuticals, Inc.

Mr. David A. Socks has made 42 insider trades between 2020-2021, according to the Form 4 filled with the SEC. Most recently he sold 2,529 units of PHAT stock worth $81,052 on 8 Oct 2021.

The largest trade he's ever made was exercising 48,212 units of PHAT stock on 17 Dec 2020. As of 8 Oct 2021 he still owns at least 1,211,346 units of PHAT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 2,529 $32.05 $81,052
Sale
Common Stock 15,471 $32.66 $505,345
Sale
Common Stock 4,100 $32.06 $131,446
Sale
Common Stock 13,900 $33.05 $459,339
Sale
Common Stock 18,000 $30.98 $557,658
Sale
Common Stock 13,960 $34 $474,654
Sale
Common Stock 26,040 $34.58 $900,385
Sale
Common Stock 26,040 $34.58 $900,385
Sale
Common Stock 3,482 $34.65 $120,665
Sale
Common Stock 3,482 $34.65 $120,665
Sale
Common Stock 36,518 $32.71 $1,194,358
Sale
Common Stock 36,518 $32.71 $1,194,358
Sale
Common Stock 17,882 $36.58 $654,195
Sale
Common Stock 17,882 $36.58 $654,195
Sale
Common Stock 22,118 $36.41 $805,405
Sale
Common Stock 22,118 $36.41 $805,405
Sale
Common Stock 22,118 $36.41 $805,405
Sale
Common Stock 500 N/A N/A
Sale
Common Stock 42,429 N/A N/A
Sale
Common Stock 42,429 $23.59 $1,000,900
Sale
Common Stock 12,071 $16.11 $194,403
Sale
Common Stock 12,071 N/A N/A
Sale
Common Stock 12,071 $49.09 $592,553
Sale
Common Stock 4,984 $43.52 $216,879
Sale
Common Stock 4,984 $14.45 $72,014
Sale
Common Stock 4,984 $43.52 $216,879
Sale
Common Stock 20,140 $31.01 $624,441
Sale
Common Stock 20,140 $46.09 $928,313
Sale
Common Stock 20,140 $46.09 $928,313
Sale
Common Stock 44,876 $46.91 $2,104,909
Sale
Common Stock 44,876 $46.91 $2,104,909
Sale
Common Stock 27,165 N/A N/A
Sale
Common Stock 12,835 N/A N/A
Sale
Common Stock 48,212 $27.81 $1,340,776
Sale
Common Stock 31,446 $35.85 $1,127,339
Sale
Common Stock 31,446 $47.69 $1,499,565
Sale
Common Stock 31,446 N/A N/A
Sale
Common Stock 6,877 $13.45 $92,523
Sale
Common Stock 6,877 $39.25 $269,943
Sale
Common Stock 12,681 $28.12 $356,602
Sale
Common Stock 12,681 $42.23 $535,455
Sale
Common Stock 10,784 $28.89 $311,539

Phathom Pharmaceuticals key executives

Phathom Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: